denali therapeutics stock price

As of 155pm ET. 26 2019 at 822 am.

Denali Therapeutics Dnli Market Capitalization

Get a real-time Denali Therapeutics Inc.

. Get the latest Denali Therapeutics DNLI detailed stock quotes stock data Real-Time ECN charts stats and more. According to the issued ratings of 8 analysts in the last year the consensus rating for Denali Therapeutics stock is Buy based on the current 8 buy ratings for DNLI. This move can be attributable to notable volume.

Denali Therapeutics NASDAQ Updated Mar 18 2022 956 PM. 2961 061 210 Volume. ET by Tomi Kilgore Denali Therapeutics started at buy with 35 stock price target at Instinet.

Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential. BATS BZX Real-Time Price. DNLI shares rallied 75 in the last trading session to close at 3513.

Denali Therapeutics Inc stocks price quote with latest real-time prices charts financials latest news technical analysis and opinions. Last 031522 EDT. The average Denali Therapeutics stock price prediction forecasts a potential upside of 17033 from the current DNLI share price of 3320.

The stocks open price was 3409. Denali Therapeutics Inc NASDAQ. With Denali Therapeutics stock trading at 2961 per share the total value of Denali Therapeutics stock market capitalization is 364B.

On average Wall Street analysts predict. According to analysts consensus price target of 9114 Denali Therapeutics has a forecasted upside of 1603 from its current price of 3501. Get Denali Therapeutics Inc D2NL3-BRSao Paulo Stock Exchange real-time stock quotes news price and financial information from CNBC.

ET View Interactive DNLI Charts. Denali Therapeutics is a biotechnology business based in the US. Thats higher than the PS ratio of 9727 of US stocks.

Denali Therapeutics stocks DNLIUS are listed on the NASDAQ and all prices are listed in US Dollars. Denali Therapeutics stock was originally listed at a price of 2145 in Dec 8 2017. Denali Therapeutics is trading at 3320 as of the 28th of March 2022.

DNLI has gained 162 504 and sits at 3389 as of 115623 est on April 1. View Denali Therapeutics DNLI investment stock information. Over the past twelve months DNLI has reported earnings growth of -50461 putting it ahead of only 396 of US stocks in our set.

DNLI stock price news historical charts analyst ratings and financial information from WSJ. Denali Therapeutics employs 380 staff and has a trailing 12-month revenue of around 487 million. Amount of Analyst Coverage Denali Therapeutics has only been the subject of 3 research reports in the past 90 days.

Denali Therapeutics Inc. Its last market close was 741 a decrease of 385 over the previous week. Price as of March 16 2022 938 am.

DNLI Denali Therapeutics Stock Price and Discussion Stocktwits. Get the latest Denali Therapeutics detailed stock quotes stock trade data stock price info and performance analysis including Denali Stock investment advice charts stats and more. The average twelve-month price target for Denali Therapeutics is 9114 with a high price target of 11100 and a low price target of 7000.

DNLI stock price quote with breaking news financials statistics charts and more. View the latest Denali Therapeutics Inc. Wedbush Cuts Denali Therapeutics Price Target to 62 From 72 Citing Expense Guidance.

Common Stock DNLI Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets. Denali Therapeutics started at neutral with 19 stock price target at Wedbush Sep. DNLI 3513 245 750 Post-Market 004 011 1248.

RT Quote NASDAQ USD. That Denali Therapeuticss share price could reach 8975 by Sep 21 2022. This is a -261 down since the beginning of the trading day.

DNLIs pricesales ratio is 7803.

Denali Therapeutics Price Target Analyst Ratings Nasdaq Dnli